IDEAYA Biosciences
230 employees
Biotech/Pharma
Public · $263.0M
Open positions (16)
Company details
Team Size230
IndustryBiotech/Pharma
Funding
Total raised
$263.0M
Last stage
Public
Investors
Celgene
Total raised
$263.0M
Last stage
Public
Investors
Yujiro Hata
Incorporated IDEAYA Biosciences in June 2015 as its first employee and Founder/CEO, led the company's IPO on NASDAQ in May 2019 (NASDAQ: IDYA). Previously COO at Flexus Biosciences (acquired by BMS) and Executive-in-Residence at 5AM Ventures.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.